43 related articles for article (PubMed ID: 23242614)
1. Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes.
Hanker LC; Rody A; Holtrich U; Pusztai L; Ruckhaeberle E; Liedtke C; Ahr A; Heinrich TM; Sänger N; Becker S; Karn T
Breast Cancer Res Treat; 2013 Jan; 137(2):407-16. PubMed ID: 23242614
[TBL] [Abstract][Full Text] [Related]
2. A clinically relevant gene signature in triple negative and basal-like breast cancer.
Rody A; Karn T; Liedtke C; Pusztai L; Ruckhaeberle E; Hanker L; Gaetje R; Solbach C; Ahr A; Metzler D; Schmidt M; Müller V; Holtrich U; Kaufmann M
Breast Cancer Res; 2011 Oct; 13(5):R97. PubMed ID: 21978456
[TBL] [Abstract][Full Text] [Related]
3. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
Rody A; Holtrich U; Pusztai L; Liedtke C; Gaetje R; Ruckhaeberle E; Solbach C; Hanker L; Ahr A; Metzler D; Engels K; Karn T; Kaufmann M
Breast Cancer Res; 2009; 11(2):R15. PubMed ID: 19272155
[TBL] [Abstract][Full Text] [Related]
4. A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways.
Hamy AS; Bonsang-Kitzis H; Lae M; Moarii M; Sadacca B; Pinheiro A; Galliot M; Abecassis J; Laurent C; Reyal F
PLoS One; 2016; 11(12):e0167397. PubMed ID: 28005906
[TBL] [Abstract][Full Text] [Related]
5. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
[TBL] [Abstract][Full Text] [Related]
6. The molecular portraits of breast tumors are conserved across microarray platforms.
Hu Z; Fan C; Oh DS; Marron JS; He X; Qaqish BF; Livasy C; Carey LA; Reynolds E; Dressler L; Nobel A; Parker J; Ewend MG; Sawyer LR; Wu J; Liu Y; Nanda R; Tretiakova M; Ruiz Orrico A; Dreher D; Palazzo JP; Perreard L; Nelson E; Mone M; Hansen H; Mullins M; Quackenbush JF; Ellis MJ; Olopade OI; Bernard PS; Perou CM
BMC Genomics; 2006 Apr; 7():96. PubMed ID: 16643655
[TBL] [Abstract][Full Text] [Related]
7. E2F4 regulatory program predicts patient survival prognosis in breast cancer.
Khaleel SS; Andrews EH; Ung M; DiRenzo J; Cheng C
Breast Cancer Res; 2014 Dec; 16(6):486. PubMed ID: 25440089
[TBL] [Abstract][Full Text] [Related]
8. Clinical and multiple gene expression variables in survival analysis of breast cancer: analysis with the hypertabastic survival model.
Tabatabai MA; Eby WM; Nimeh N; Li H; Singh KP
BMC Med Genomics; 2012 Dec; 5():63. PubMed ID: 23241496
[TBL] [Abstract][Full Text] [Related]
9. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes.
Pittman J; Huang E; Dressman H; Horng CF; Cheng SH; Tsou MH; Chen CM; Bild A; Iversen ES; Huang AT; Nevins JR; West M
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8431-6. PubMed ID: 15152076
[TBL] [Abstract][Full Text] [Related]
10. Stromal B Lymphocytes Affecting Prognosis in Triple-Negative Breast Cancer by Opal/TSA Multiplexed Immunofluorescence.
Fang M; Yin W; Qiu C; Song T; Lin B; Wang Y; Xiong H; Wu S
Int J Womens Health; 2024; 16():755-767. PubMed ID: 38706691
[TBL] [Abstract][Full Text] [Related]
11. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.
Zareinejad M; Mehdipour F; Roshan-Zamir M; Faghih Z; Ghaderi A
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835465
[TBL] [Abstract][Full Text] [Related]
12. Polarization of Melatonin-Modulated Colostrum Macrophages in the Presence of Breast Tumor Cell Lines.
Silva KMR; França DCH; de Queiroz AA; Fagundes-Triches DLG; de Marchi PGF; Morais TC; Honorio-França AC; França EL
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569777
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
[No Abstract] [Full Text] [Related]
14. Accurate prediction of breast cancer survival through coherent voting networks with gene expression profiling.
Pellegrini M
Sci Rep; 2021 Jul; 11(1):14645. PubMed ID: 34282236
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer.
Wali VB; Patwardhan GA; Pelekanou V; Karn T; Cao J; Ocana A; Yan Q; Nelson B; Hatzis C; Pusztai L
Sci Rep; 2019 Oct; 9(1):14934. PubMed ID: 31624295
[TBL] [Abstract][Full Text] [Related]
16. High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.
Yeong J; Lim JCT; Lee B; Li H; Chia N; Ong CCH; Lye WK; Putti TC; Dent R; Lim E; Thike AA; Tan PH; Iqbal J
Front Immunol; 2018; 9():1209. PubMed ID: 29899747
[TBL] [Abstract][Full Text] [Related]
17. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.
Shen M; Wang J; Ren X
Front Immunol; 2018; 9():470. PubMed ID: 29568299
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.
Zhao Z; Wang S; Lin Y; Miao Y; Zeng Y; Nie Y; Guo P; Jiang G; Wu J
Oncol Lett; 2017 Jun; 13(6):4577-4584. PubMed ID: 28599458
[TBL] [Abstract][Full Text] [Related]
20. The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.
Flynn NJ; Somasundaram R; Arnold KM; Sims-Mourtada J
Target Oncol; 2017 Apr; 12(2):139-152. PubMed ID: 28281220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
